Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ramoplanin: a lipoglycodepsipeptide antibiotic.

Debra K Farver1, Dennis D Hedge, Steven C Lee

  • 1College of Pharmacy, South Dakota State University, Yankton, SD 57078-7600, USA. debra.farver@state.sd.us

The Annals of Pharmacotherapy
|March 24, 2005
PubMed
Summary

Ramoplanin is a lipoglycodepsipeptide antibiotic effective against gram-positive bacteria by inhibiting peptidoglycan synthesis. Ongoing trials explore its use for Clostridium difficile-associated diarrhea.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Insights into the Interphase between the Na Metal Anode and Sulfide Solid-State Electrolytes: A Joint Experimental and Computational Study.

ACS applied materials & interfaces·2018
Same author

Interprofessional education in pharmacology using high-fidelity simulation.

Currents in pharmacy teaching & learning·2017
Same author

Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures.

Journal of clinical pharmacology·2017
Same author

Validity and reliability of a practitioner service tool: potential resource for assessing faculty practitioners.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2013
Same author

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?

Risk management and healthcare policy·2012
Same author

Gabapentin enacarbil for treatment of restless legs syndrome in adults.

The Annals of pharmacotherapy·2012

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Ramoplanin is a lipoglycodepsipeptide antibiotic.
  • It targets gram-positive bacteria by inhibiting peptidoglycan synthesis.

Purpose of the Study:

  • To review the pharmacology, antimicrobial activity, pharmacokinetics, clinical applications, and safety of ramoplanin.
  • To assess its potential in treating Clostridium difficile-associated diarrhea.

Main Methods:

  • Literature review of MEDLINE and BIOSIS databases (1984-2004).
  • Inclusion of data from Oscient Pharmaceuticals.
  • Analysis of English-based articles and abstracts.

Main Results:

  • Ramoplanin demonstrates bactericidal activity against gram-positive bacteria by blocking peptidoglycan synthesis.

Related Experiment Videos

  • In vitro studies show efficacy against antibiotic-resistant gram-positive pathogens.
  • Clinical trials are evaluating oral ramoplanin for Clostridium difficile-associated diarrhea; previous trials assessed vancomycin-resistant Enterococcus suppression. Minimal adverse effects and no documented drug-drug interactions.

    • Conclusions:

    • Ramoplanin exhibits promising antimicrobial properties against gram-positive pathogens.
    • Further clinical trials are necessary to confirm its role in treating Clostridium difficile-associated diarrhea.